Former CEO David Lazar Completes Departure from KALA BIO Board

summarizeSummary

David Lazar, who previously resigned as CEO and CFO, has now also resigned from KALA BIO's Board of Directors, signifying his complete departure from the company's leadership.

check_boxKey Events

• Director Resignation

  David Lazar resigned from the Board of Directors of KALA BIO, Inc., effective February 16, 2026.

• Complete Leadership Departure

  This follows his earlier resignation as CEO and CFO on February 5, 2026, and his disclosure as Chairman on February 6, 2026, signifying his full separation from all executive and board roles at the company.

• Context of Financial Challenges

  This leadership change occurs amidst recent dilutive financing on February 2, 2026, and the finalization of a registration for the resale of 241.4 million shares by selling stockholders on February 17, 2026, highlighting ongoing capital and operational pressures.

auto_awesomeAnalysis

This filing marks the complete separation of David Lazar from KALA BIO's leadership, following his earlier resignation as CEO and CFO. While the company states the resignation was not due to disagreements, the full departure of a former executive and board member during a period of significant financial challenges (including recent dilutive financing, a large share resale registration, and an existing ATM program) could raise concerns about leadership stability and strategic direction. Investors will likely monitor for further leadership changes or strategic announcements as the company navigates its current challenges.